HEADER VIRAL PROTEIN/IMMUNE SYSTEM 14-APR-25 9UHG TITLE JN.1 RBD IN COMPLEX WITH ANTIBODY BA5-12-CDR1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RECEPTOR-BINDING DOMAIN (RBD); COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: BA5-12-CDR1-H; COMPND 8 CHAIN: I; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: BA5-12-CDR1-L; COMPND 12 CHAIN: M; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 STRAIN: OMICRON/JN.1; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, COMPLEX, VIRAL PROTEIN, ANTIBODY, VIRAL PROTEIN/IMMUNE KEYWDS 2 SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR C.YUE,X.MAO REVDAT 1 22-JUL-26 9UHG 0 JRNL AUTH C.YUE,X.MAO JRNL TITL JN.1 RBD IN COMPLEX WITH ANTIBODY BA5-12-CDR1 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, PHENIX, COOT REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.910 REMARK 3 NUMBER OF PARTICLES : 191531 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9UHG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 23-MAY-25. REMARK 100 THE DEPOSITION ID IS D_1300056537. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : JN.1 RBD IN COMPLEX WITH REMARK 245 ANTIBODY BA5-12-CDR1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : DARK FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I, M, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN A 439 OG SER A 443 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 346 39.47 -99.47 REMARK 500 PHE A 375 -60.50 -94.04 REMARK 500 LYS A 386 53.44 -96.10 REMARK 500 PHE A 400 -175.94 -171.25 REMARK 500 LYS A 444 -169.67 -79.52 REMARK 500 ASN A 487 -6.71 72.63 REMARK 500 ASN I 32 -169.15 -161.62 REMARK 500 VAL I 48 -62.79 -90.74 REMARK 500 ARG I 103 -169.43 -127.50 REMARK 500 MET I 106 40.62 -104.08 REMARK 500 ASN M 30 -136.51 55.30 REMARK 500 ALA M 51 -4.05 67.17 REMARK 500 ALA M 84 -169.11 -167.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-64163 RELATED DB: EMDB REMARK 900 JN.1 RBD IN COMPLEX WITH ANTIBODY BA5-12-CDR1 DBREF 9UHG A 332 530 UNP P0DTC2 SPIKE_SARS2 332 530 DBREF 9UHG I 1 119 PDB 9UHG 9UHG 1 119 DBREF 9UHG M 1 107 PDB 9UHG 9UHG 1 107 SEQADV 9UHG VAL A 332 UNP P0DTC2 ILE 332 CONFLICT SEQADV 9UHG HIS A 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 9UHG THR A 356 UNP P0DTC2 LYS 356 CONFLICT SEQADV 9UHG PHE A 371 UNP P0DTC2 SER 371 VARIANT SEQADV 9UHG PRO A 373 UNP P0DTC2 SER 373 VARIANT SEQADV 9UHG PHE A 375 UNP P0DTC2 SER 375 VARIANT SEQADV 9UHG ALA A 376 UNP P0DTC2 THR 376 VARIANT SEQADV 9UHG LYS A 403 UNP P0DTC2 ARG 403 CONFLICT SEQADV 9UHG ASN A 405 UNP P0DTC2 ASP 405 VARIANT SEQADV 9UHG SER A 408 UNP P0DTC2 ARG 408 VARIANT SEQADV 9UHG ASN A 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 9UHG LYS A 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 9UHG HIS A 445 UNP P0DTC2 VAL 445 CONFLICT SEQADV 9UHG SER A 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 9UHG ASP A 450 UNP P0DTC2 ASN 450 CONFLICT SEQADV 9UHG TRP A 452 UNP P0DTC2 LEU 452 CONFLICT SEQADV 9UHG SER A 455 UNP P0DTC2 LEU 455 CONFLICT SEQADV 9UHG LYS A 460 UNP P0DTC2 ASN 460 VARIANT SEQADV 9UHG ASN A 477 UNP P0DTC2 SER 477 VARIANT SEQADV 9UHG LYS A 478 UNP P0DTC2 THR 478 VARIANT SEQADV 9UHG LYS A 481 UNP P0DTC2 ASN 481 CONFLICT SEQADV 9UHG A UNP P0DTC2 VAL 483 DELETION SEQADV 9UHG LYS A 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 9UHG PRO A 486 UNP P0DTC2 PHE 486 VARIANT SEQADV 9UHG ARG A 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 9UHG TYR A 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 9UHG HIS A 505 UNP P0DTC2 TYR 505 VARIANT SEQRES 1 A 198 VAL THR ASN LEU CYS PRO PHE HIS GLU VAL PHE ASN ALA SEQRES 2 A 198 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG THR ARG SEQRES 3 A 198 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 4 A 198 PHE ALA PRO PHE PHE ALA PHE LYS CYS TYR GLY VAL SER SEQRES 5 A 198 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 6 A 198 ALA ASP SER PHE VAL ILE LYS GLY ASN GLU VAL SER GLN SEQRES 7 A 198 ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN SEQRES 8 A 198 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 9 A 198 TRP ASN SER ASN LYS LEU ASP SER LYS HIS SER GLY ASN SEQRES 10 A 198 TYR ASP TYR TRP TYR ARG SER PHE ARG LYS SER LYS LEU SEQRES 11 A 198 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 12 A 198 ALA GLY ASN LYS PRO CYS LYS GLY LYS GLY PRO ASN CYS SEQRES 13 A 198 TYR PHE PRO LEU GLN SER TYR GLY PHE ARG PRO THR TYR SEQRES 14 A 198 GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 A 198 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 16 A 198 LYS LYS SER SEQRES 1 I 119 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU ILE GLN SEQRES 2 I 119 PRO GLY GLY SER VAL ARG LEU SER CYS THR VAL SER GLY SEQRES 3 I 119 PHE THR VAL SER SER ASN TYR MET SER TRP VAL ARG GLN SEQRES 4 I 119 SER PRO GLY ARG GLY LEU GLU TRP VAL SER LEU ILE TYR SEQRES 5 I 119 PRO GLY GLY SER SER TYR TYR ALA ASP SER VAL LYS GLY SEQRES 6 I 119 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 I 119 TYR LEU GLN MET ASN SER LEU ARG GLY GLU ASP THR ALA SEQRES 8 I 119 VAL TYR TYR CYS VAL ARG ASP MET VAL GLY ALA ARG ALA SEQRES 9 I 119 GLY MET GLU VAL TRP GLY GLN GLY THR THR VAL THR VAL SEQRES 10 I 119 SER SER SEQRES 1 M 107 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 M 107 SER VAL GLY ASP ARG VAL THR PHE THR CYS GLN ALA SER SEQRES 3 M 107 GLN ASP ILE ASN ILE TYR LEU ASN TRP TYR GLN GLN LYS SEQRES 4 M 107 THR GLY LYS ALA PRO LYS LEU LEU ILE TYR ASP ALA SER SEQRES 5 M 107 ASN LEU GLU THR GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 M 107 GLY SER GLY THR GLU PHE THR PHE THR ILE SER SER LEU SEQRES 7 M 107 GLN PRO GLU ASP ILE ALA THR TYR TYR CYS LEU GLN TYR SEQRES 8 M 107 ASP ASN LEU PRO ARG ALA PHE GLY GLN GLY THR LYS VAL SEQRES 9 M 107 GLU ILE LYS HET NAG B 1 14 HET NAG B 2 14 HET NAG A 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 3(C8 H15 N O6) HELIX 1 AA1 PHE A 338 ASN A 343 5 6 HELIX 2 AA2 TYR A 365 ALA A 372 1 8 HELIX 3 AA3 SER A 383 LEU A 387 5 5 HELIX 4 AA4 THR I 28 ASN I 32 5 5 HELIX 5 AA5 ASP I 61 LYS I 64 5 4 HELIX 6 AA6 GLN M 79 ILE M 83 5 5 SHEET 1 AA1 5 ASN A 354 ILE A 358 0 SHEET 2 AA1 5 ASN A 394 ILE A 402 -1 O ALA A 397 N THR A 356 SHEET 3 AA1 5 TYR A 508 GLU A 516 -1 O SER A 514 N TYR A 396 SHEET 4 AA1 5 THR A 430 ASN A 437 -1 N THR A 430 O PHE A 515 SHEET 5 AA1 5 LYS A 378 CYS A 379 -1 N LYS A 378 O VAL A 433 SHEET 1 AA2 2 TRP A 452 ARG A 454 0 SHEET 2 AA2 2 LEU A 492 SER A 494 -1 O GLN A 493 N TYR A 453 SHEET 1 AA3 4 GLN I 3 SER I 7 0 SHEET 2 AA3 4 LEU I 20 SER I 25 -1 O THR I 23 N VAL I 5 SHEET 3 AA3 4 THR I 77 GLN I 81 -1 O LEU I 78 N CYS I 22 SHEET 4 AA3 4 THR I 68 ASP I 72 -1 N THR I 68 O GLN I 81 SHEET 1 AA4 6 LEU I 11 ILE I 12 0 SHEET 2 AA4 6 THR I 113 VAL I 117 1 O THR I 116 N ILE I 12 SHEET 3 AA4 6 ALA I 91 VAL I 96 -1 N ALA I 91 O VAL I 115 SHEET 4 AA4 6 MET I 34 GLN I 39 -1 N GLN I 39 O VAL I 92 SHEET 5 AA4 6 GLU I 46 ILE I 51 -1 O VAL I 48 N TRP I 36 SHEET 6 AA4 6 SER I 57 TYR I 59 -1 O TYR I 58 N LEU I 50 SHEET 1 AA5 4 MET M 4 SER M 7 0 SHEET 2 AA5 4 VAL M 19 ALA M 25 -1 O THR M 22 N SER M 7 SHEET 3 AA5 4 THR M 72 ILE M 75 -1 O PHE M 73 N PHE M 21 SHEET 4 AA5 4 PHE M 62 SER M 65 -1 N SER M 65 O THR M 72 SHEET 1 AA6 6 SER M 10 SER M 12 0 SHEET 2 AA6 6 THR M 102 GLU M 105 1 O LYS M 103 N LEU M 11 SHEET 3 AA6 6 THR M 85 GLN M 90 -1 N TYR M 86 O THR M 102 SHEET 4 AA6 6 ASN M 34 GLN M 38 -1 N ASN M 34 O LEU M 89 SHEET 5 AA6 6 LYS M 45 TYR M 49 -1 O LYS M 45 N GLN M 37 SHEET 6 AA6 6 ASN M 53 LEU M 54 -1 O ASN M 53 N TYR M 49 SHEET 1 AA7 4 SER M 10 SER M 12 0 SHEET 2 AA7 4 THR M 102 GLU M 105 1 O LYS M 103 N LEU M 11 SHEET 3 AA7 4 THR M 85 GLN M 90 -1 N TYR M 86 O THR M 102 SHEET 4 AA7 4 ALA M 97 PHE M 98 -1 O ALA M 97 N GLN M 90 SSBOND 1 CYS A 336 CYS A 361 1555 1555 2.03 SSBOND 2 CYS A 379 CYS A 432 1555 1555 2.03 SSBOND 3 CYS A 480 CYS A 488 1555 1555 2.03 SSBOND 4 CYS I 22 CYS I 95 1555 1555 2.03 SSBOND 5 CYS M 23 CYS M 88 1555 1555 2.04 LINK ND2 ASN A 343 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 354 C1 NAG A 601 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 CISPEP 1 SER M 7 PRO M 8 0 -6.20 CISPEP 2 LEU M 94 PRO M 95 0 -2.72 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 36 247 CONECT 99 3322 CONECT 190 3350 CONECT 247 36 CONECT 396 801 CONECT 801 396 CONECT 1207 1254 CONECT 1254 1207 CONECT 1740 2318 CONECT 2318 1740 CONECT 2658 3167 CONECT 3167 2658 CONECT 3322 99 3323 3333 CONECT 3323 3322 3324 3330 CONECT 3324 3323 3325 3331 CONECT 3325 3324 3326 3332 CONECT 3326 3325 3327 3333 CONECT 3327 3326 3334 CONECT 3328 3329 3330 3335 CONECT 3329 3328 CONECT 3330 3323 3328 CONECT 3331 3324 CONECT 3332 3325 3336 CONECT 3333 3322 3326 CONECT 3334 3327 CONECT 3335 3328 CONECT 3336 3332 3337 3347 CONECT 3337 3336 3338 3344 CONECT 3338 3337 3339 3345 CONECT 3339 3338 3340 3346 CONECT 3340 3339 3341 3347 CONECT 3341 3340 3348 CONECT 3342 3343 3344 3349 CONECT 3343 3342 CONECT 3344 3337 3342 CONECT 3345 3338 CONECT 3346 3339 CONECT 3347 3336 3340 CONECT 3348 3341 CONECT 3349 3342 CONECT 3350 190 3351 3361 CONECT 3351 3350 3352 3358 CONECT 3352 3351 3353 3359 CONECT 3353 3352 3354 3360 CONECT 3354 3353 3355 3361 CONECT 3355 3354 3362 CONECT 3356 3357 3358 3363 CONECT 3357 3356 CONECT 3358 3351 3356 CONECT 3359 3352 CONECT 3360 3353 CONECT 3361 3350 3354 CONECT 3362 3355 CONECT 3363 3356 MASTER 137 0 3 6 31 0 0 6 3360 3 54 35 END